ACELRX PHARMACEUTICALS, INC.

Serial Number 86877385
Registration 5088328
702

Registration Progress

Application Filed
Jan 15, 2016
Under Examination
Aug 9, 2016
Approved for Publication
Jun 14, 2016
Published for Opposition
Jun 14, 2016
Registered
Nov 22, 2016

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161122)
Due: Nov 22, 2026 302 days

Trademark Image

ACELRX PHARMACEUTICALS, INC.

Basic Information

Serial Number
86877385
Registration Number
5088328
Filing Date
January 15, 2016
Registration Date
November 22, 2016
Published for Opposition
June 14, 2016
Drawing Code
5

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 1, 2023
Registration
Registered
Classes
005 010

Rights Holder

AcelRx Pharmaceuticals, Inc.

03
Address
351 Galveston Drive
Redwood City, CA 94063

Ownership History

AcelRx Pharmaceuticals, Inc.

Original Applicant
03
Redwood City, CA

AcelRx Pharmaceuticals, Inc.

Owner at Publication
03
Redwood City, CA

AcelRx Pharmaceuticals, Inc.

Original Registrant
03
Redwood City, CA

Legal Representation

Attorney
Brendan J. Hughes

USPTO Deadlines

Next Deadline
302 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20161122)
Due Date
November 22, 2026
Grace Period Ends
May 22, 2027

Application History

30 events
Date Code Type Description Documents
Sep 5, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 5, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 5, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 5, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 2, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 1, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 1, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 22, 2022 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Nov 22, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 22, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 20, 2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 19, 2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 11, 2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 19, 2016 IUAF S USE AMENDMENT FILED Loading...
Oct 5, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 19, 2016 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 9, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 14, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 14, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 25, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 26, 2016 ALIE A ASSIGNED TO LIE Loading...
Apr 11, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 11, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 11, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 11, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 11, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 4, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 21, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 19, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for treating pain; pharmaceutical preparations for treating anxiety
First Use Anywhere: Sep 19, 2016
First Use in Commerce: Sep 19, 2016
Class 010
Drug delivery systems; medical device, namely, a mechanical and electronic device used to administer medications, perform timed medication delivery, and to provide secure access to and delivery of medications
First Use Anywhere: Sep 19, 2016
First Use in Commerce: Sep 19, 2016

Additional Information

Design Mark
The mark consists of the trademark "AcelRx Pharmaceuticals, Inc." in which the term "AcelRx" in blue and gray is above the terms "Phamaceuticals, Inc." in gray. "AcelRx" features a capital letter "A" and lower case letters "cel" all in blue to the left of the capital letter "R" in gray followed by a stylized letter "x". The left crossbars of the letter "x" are elongated and in blue and the right crossbars of the letter "x" are smaller and in gray.
Color Claim
The color(s) blue and gray is/are claimed as a feature of the mark.

Classification

International Classes
005 010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS, INC."